SCHEMBL30784412

SCHEMBL30784412

Cn1c(N2CCOCC2)nc2ccc(F)cc2c1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPV4 Q9HBA0 2/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ PIK3CD O00329 4/20 0.45
▸ PIK3CB P42338 4/20 0.45
▸ ALDH1A1 P00352 3/20 0.44
▸ HSD17B10 Q99714 3/20 0.44
▸ TSHR P16473 2/20 0.44
▸ CYP1A2 P05177 2/20 0.44
▸ GLA P06280 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CASP1 P29466 1/20 0.44
▸ CASP7 P55210 1/20 0.44
▸ HIF1A Q16665 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ TDO2 P48775 4/20 0.43
▸ IDO2 Q6ZQW0 4/20 0.43
▸ IDO1 P14902 3/20 0.43
▸ KDM4E B2RXH2 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30784308 0.86 ATM (0.52) SMN1; SMN2NPC1RAB9APIK3CDPIK3CB
SCHEMBL30784114 0.78 HTT (0.42) SMN1; SMN2RAB9APIK3CDPIK3CBALDH1A1
SCHEMBL30783815 0.75 ALDH1A1 (0.43) SMN1; SMN2PIK3CDPIK3CBALDH1A1HSD17B10
SCHEMBL17537349 0.75 KDM4E (0.64) SMN1; SMN2NPC1RAB9AALDH1A1HSD17B10
SCHEMBL30783853 0.74 HTT (0.39) TRPV4SMN1; SMN2RAB9AALDH1A1HSD17B10
SCHEMBL30784396 0.74 HTT (0.39) SMN1; SMN2RAB9APIK3CDPIK3CBALDH1A1
SCHEMBL30783830 0.74 HTT (0.39) SMN1; SMN2RAB9APIK3CDPIK3CBALDH1A1
SCHEMBL31427755 0.73 POLB (0.47) TRPV4SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL30784067 0.73 HTT (0.39) TRPV4SMN1; SMN2RAB9APIK3CDPIK3CB
SCHEMBL9919072 0.73 POLB (0.55) GLATDO2IDO2IDO1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026424-A1 QUINAZOLINONE DERIVATIVES AS AND RELATED USES BLACK DIAMOND THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback